In 1990, the Radionuclide Experiment Facility was launched in Osaka University Graduate School of Medicine for biological and medical research. In 2010, Positron Emission Tomography (PET) Molecular Imaging Center was launched for further imaging experiments with cyclotron, radiopharmaceutical tracer synthesis system, animal PET/CT, and PET/MR camera.
    This year, the Radionuclide Experiment Facility and PET Molecular Imaging Center was combined and transformed to Medical Imaging Center for Translational Research (TMIC) which consists of three Divisions; Division of Basic Research, Division of Radiation Safety, and Division of PET Molecular Imaging. This Center is managed under the Good-Laboratory-Practice (GLP) level. A number of university, academic institution, industry/company are utilizing this center for their independent research projects. The effectiveness of myocardial sheets were proved on the molecular basis by means of PET. New molecular biomarker to test the effect anti-cancer drugs is being developed.
   This Center is nominated as an official education/training platform of International Atomic Energy Agency (IAEA) to promote use of radionuclide for medicine. We are accepting researchers, physicians, nurses, technologists, and officers who are interested in nuclear medicine and molecular imaging around the world.

  Translational research and imaging is one of the farthest frontier of medicine working together with nuclear physics, radiochemistry, radiopharmaceutical science, medical engineering, bioinformatics, computer science, and clinical medicine. I believe TMIC contributes to this field.

June 1st,2016